Familial Adenomatous Polyposis

• Familial Adenomatous Polyposis (FAP) is a genetic condition causing hundreds to thousands of polyps in the large intestine.
• It is caused by a mutation in the APC gene and carries a nearly 100% risk of colorectal cancer if untreated.
• Symptoms often include rectal bleeding, changes in bowel habits, and abdominal pain, typically appearing in adolescence.
• Genetic testing is crucial for diagnosis and identifying at-risk family members.
• Prophylactic surgery, usually a colectomy, is the primary and most effective treatment to prevent cancer.

What is Familial Adenomatous Polyposis (FAP)?

Familial Adenomatous Polyposis (FAP) is an autosomal dominant inherited condition primarily characterized by the development of hundreds to thousands of adenomatous polyps throughout the colon and rectum. This genetic disorder is caused by a germline mutation in the adenomatous polyposis coli (APC) gene, a tumor suppressor gene located on chromosome 5. The presence of these polyps significantly increases the risk of developing colorectal cancer, with nearly 100% of individuals with FAP developing cancer by age 40 if the condition remains untreated.

Understanding what is Familial Adenomatous Polyposis is crucial for early detection and management. While rare, affecting approximately 1 in 10,000 to 1 in 15,000 individuals worldwide according to major health organizations, FAP accounts for about 1% of all colorectal cancer cases. The penetrance of the APC gene mutation is very high, meaning most individuals who inherit the mutation will develop the condition. This makes early diagnosis and proactive management essential for improving patient outcomes.

Recognizing Familial Adenomatous Polyposis Symptoms

The manifestation of Familial Adenomatous Polyposis symptoms often begins in adolescence or early adulthood, though the exact age can vary. Initially, symptoms may be subtle or non-specific, making early diagnosis challenging without a family history. As the number and size of polyps increase, more noticeable symptoms typically emerge. These can be indicative of irritation, inflammation, or bleeding within the gastrointestinal tract.

Common symptoms associated with FAP include:

• Rectal bleeding: Often one of the earliest and most common signs, resulting from polyps bleeding.
• Changes in bowel habits: This can manifest as persistent diarrhea or constipation, or an alternating pattern.
• Abdominal pain: Discomfort or cramping in the abdomen may occur.
• Weight loss: Unexplained weight loss can be a symptom, particularly if the disease is advanced.
• Anemia: Chronic blood loss from polyps can lead to iron-deficiency anemia, causing fatigue and weakness.

Beyond gastrointestinal issues, FAP can also present with extra-colonic manifestations, which are signs and symptoms outside the colon. These can include benign bone growths (osteomas), soft tissue tumors (desmoid tumors), dental abnormalities, and congenital hypertrophy of the retinal pigment epithelium (CHRPE), which are pigmented lesions in the eye. Recognition of these diverse symptoms is important for a comprehensive diagnostic approach.

FAP Genetic Testing and Treatment Options

FAP genetic testing plays a pivotal role in the diagnosis and management of Familial Adenomatous Polyposis. This testing involves a blood sample to analyze the APC gene for known mutations. For individuals with a family history of FAP, genetic testing can confirm the diagnosis and allow for presymptomatic identification of at-risk relatives, enabling early surveillance and intervention. Genetic counseling is an integral part of this process, helping families understand the implications of the test results and make informed decisions.

The primary goal of Familial Adenomatous Polyposis treatment options is to prevent the development of colorectal cancer. Surveillance with regular colonoscopies typically begins in early adolescence for at-risk individuals. However, once numerous polyps are detected, prophylactic colectomy—surgical removal of the colon—is the cornerstone of treatment. This surgery is usually performed in the late teens or early twenties, before malignant transformation is likely to occur. Different surgical approaches exist, such as total colectomy with ileorectal anastomosis or total proctocolectomy with ileal pouch-anal anastomosis, each chosen based on the individual’s specific condition and surgeon’s recommendation.

While surgery is the definitive treatment, ongoing monitoring is essential even after colectomy, as polyps can still develop in any remaining rectal tissue or in the upper gastrointestinal tract. Non-steroidal anti-inflammatory drugs (NSAIDs) like celecoxib have shown some promise in reducing polyp burden, but they are not a substitute for surgical intervention. Regular endoscopic surveillance of the upper GI tract is also recommended due to an increased risk of duodenal polyps and cancer. Comprehensive, lifelong management is crucial for individuals with FAP to minimize cancer risk and maintain quality of life.